SCHEMBL7521094

SCHEMBL7521094

O=C(NCC1Cc2c(sc(NC(=O)C(=O)O)c2C(=O)O)CN1)OCc1ccccc1

nearest known ligand 0.45

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
PTPN1 P18031 20/20 0.45
PTPN2 P17706 10/20 0.45
PTPRC P08575 2/20 0.43
PTPRA P18433 2/20 0.39
PTPRB P23467 1/20 0.39
PTPRE P23469 1/20 0.39
PTPN6 P29350 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7515936 0.81 PTPN1 (0.43) PTPN1PTPN2PTPRCPTPRAPTPRB
SCHEMBL7522183 0.81 PTPN1 (0.46) PTPN1PTPN2PTPRCPTPRAPTPRB
SCHEMBL7519819 0.79 RAB9A (0.44) PTPN1PTPN2PTPRCPTPRAPTPRB
SCHEMBL5837619 0.79 PTPN1 (0.42) PTPN1PTPN2PTPRCPTPRAPTPRB
SCHEMBL7513085 0.79 PTPN1 (0.47) PTPN1PTPN2PTPRCPTPRAPTPRB
SCHEMBL7520290 0.78 PTPN1 (0.56) PTPN1PTPN2PTPRCPTPRAPTPRB
SCHEMBL7520327 0.78 PTPN1 (0.43) PTPN1PTPN2PTPRCPTPRAPTPRB
SCHEMBL7524649 0.77 PTPN1 (0.43) PTPN1PTPN2PTPRCPTPRAPTPRB
SCHEMBL7524247 0.77 PTPN1 (0.53) PTPN1PTPN2PTPRC
SCHEMBL5838228 0.77 RAB9A (0.45)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020099073-A1 Modulators of protein tyrosine phosphatases (PTPases) NOVO NORDISK A/S (DK) 2002-07-25 US claimed
US-20020099073-A1 Modulators of protein tyrosine phosphatases (PTPases) NOVO NORDISK A/S (DK) 2002-07-25 US disclosed
WO-2002004458-A1 MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPASES) NOVO NORDISK A/S (DK) 2002-01-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020099073-A1 Modulators of protein tyrosine phosphatases (PTPases) PTPN1, PTPRO, PTPRS PTPN1 1/4885PTPN2 14/4885PTPRC 6/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.